This HTML5 document contains 116 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-shhttp://sh.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n23https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n17http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
dbpedia-srhttp://sr.dbpedia.org/resource/
dbpedia-pthttp://pt.dbpedia.org/resource/
n12http://commons.wikimedia.org/wiki/Special:FilePath/
dbpedia-fahttp://fa.dbpedia.org/resource/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
goldhttp://purl.org/linguistics/gold/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Ravuconazole
rdf:type
yago:Compound114818238 yago:Chemical114806838 yago:Liquid114940386 yago:Material114580897 yago:Agent114778436 yago:WikicatAlcohols yago:WikicatTertiaryAlcohols yago:Substance100019613 yago:Food100021265 yago:Substance100020090 dbo:Drug yago:PhysicalEntity100001930 yago:WikicatNitriles yago:DrugOfAbuse103248958 yago:CausalAgent100007347 dbo:ChemicalSubstance yago:Beverage107881800 yago:Drug103247620 yago:Abstraction100002137 yago:Alcohol107884567 wikidata:Q8386 n17:ChemicalObject yago:Fluid114939900 yago:Matter100020827 yago:Nitrile114827346 yago:Part113809207 yago:Relation100031921 yago:OrganicCompound114727670 owl:Thing
rdfs:label
Ravuconazol Ravuconazole
rdfs:comment
Ravuconazole (codenamed BMS-207147 and ER-30346) is a potent triazole antifungal, the development of which was discontinued in 2007. The drug has shown to have a similar spectrum of activity to voriconazole, with an increased half-life. However, ravuconazole has limited activity against species of Fusarium, Scedosporium, and Zygomycetes. Ravuconazol é um fármaco antifúngico triazólico desenvolvido pela Bristol-Myers Squibb, que está em fase de testes clínicos. A droga tem demonstrado um espectro de ação similar ao voriconazol, com uma meia-vida biológica aumentada. Entretanto, o ravuconazol tem uma limitada ação contra espécies dos gêneros Fusarium, e Zygomycetes. O ravuconazol possui atividade anti-Trypanosoma in vivo e in vitro, e devido a meia-vida plasmática elevada (4 a 8 dias) em humanos faz dele uma droga promissora para ser usada no tratamento da doença de Chagas.
foaf:depiction
n12:Ravuconazole.svg
dcterms:subject
dbc:Triazole_antifungals dbc:27-Hydroxylase_inhibitors dbc:Abandoned_drugs dbc:Nitriles dbc:Thiazoles dbc:Fluoroarenes dbc:Lanosterol_14α-demethylase_inhibitors dbc:Tertiary_alcohols dbc:Phenylethanolamines
dbo:wikiPageID
25097813
dbo:wikiPageRevisionID
1110498506
dbo:wikiPageWikiLink
dbc:Phenylethanolamines dbc:Triazole_antifungals dbc:Abandoned_drugs dbr:Albaconazole dbr:Fosravuconazole dbc:Nitriles dbr:Zygomycetes dbr:Voriconazole dbc:Thiazoles dbr:Scedosporium dbr:Antifungal dbc:Fluoroarenes dbc:Lanosterol_14α-demethylase_inhibitors dbr:Isavuconazole dbr:Fusarium dbr:Triazole dbc:Tertiary_alcohols dbc:27-Hydroxylase_inhibitors
owl:sameAs
dbpedia-sr:Ravukonazol wikidata:Q7296826 freebase:m.09g9hf3 dbpedia-sh:Ravukonazol dbpedia-fa:راووکونازول dbpedia-pt:Ravuconazol n23:4tnZH yago-res:Ravuconazole
dbp:wikiPageUsesTemplate
dbt:Ebicite dbt:Short_description dbt:Fdacite dbt:Reflist dbt:Antifungals dbt:Chemspidercite dbt:Drugbox dbt:Cascite dbt:Antiinfective-drug-stub dbt:Drugbankcite dbt:Stdinchicite
dbo:thumbnail
n12:Ravuconazole.svg?width=300
dbp:atcPrefix
None
dbp:c
22
dbp:casNumber
182760
dbp:chebi
143825
dbp:chembl
294029
dbp:chemspiderid
411041
dbp:f
2
dbp:h
17
dbp:iupacName
4
dbp:n
5
dbp:o
1
dbp:pubchem
467825
dbp:s
1
dbp:smiles
C[C@@H][C@]c1ccccc1F
dbp:stdinchi
1
dbp:stdinchikey
OPAHEYNNJWPQPX-RCDICMHDSA-N
dbp:unii
95
dbp:verifiedfields
changed
dbp:verifiedrevid
406538505
dbp:watchedfields
changed
dbp:width
280
dbo:abstract
Ravuconazol é um fármaco antifúngico triazólico desenvolvido pela Bristol-Myers Squibb, que está em fase de testes clínicos. A droga tem demonstrado um espectro de ação similar ao voriconazol, com uma meia-vida biológica aumentada. Entretanto, o ravuconazol tem uma limitada ação contra espécies dos gêneros Fusarium, e Zygomycetes. O ravuconazol possui atividade anti-Trypanosoma in vivo e in vitro, e devido a meia-vida plasmática elevada (4 a 8 dias) em humanos faz dele uma droga promissora para ser usada no tratamento da doença de Chagas. Ravuconazole (codenamed BMS-207147 and ER-30346) is a potent triazole antifungal, the development of which was discontinued in 2007. The drug has shown to have a similar spectrum of activity to voriconazole, with an increased half-life. However, ravuconazole has limited activity against species of Fusarium, Scedosporium, and Zygomycetes.
dbp:niaidChemdb
57176
gold:hypernym
dbr:Antifungal
prov:wasDerivedFrom
wikipedia-en:Ravuconazole?oldid=1110498506&ns=0
dbo:wikiPageLength
3944
dbo:casNumber
182760-06-1
dbo:chEBI
143825
dbo:chEMBL
294029
dbo:fdaUniiCode
95YH599JWV
dbo:pubchem
467825
foaf:isPrimaryTopicOf
wikipedia-en:Ravuconazole